[1] MATTHAY K K, MARIS J M, SCHLEIERMACHER G, et al. Neuroblastoma[J]. Nat Rev Dis Prim, 2016, 2(1): 1-21.
[2] QIU B, MATTHAY K K. Advancing therapy for neuroblastoma[J]. Nat Rev Clin Oncol, 2022, 19(8): 515-533.
[3] ZEINELDIN M, PATEL A G, DYER M A. Neuroblastoma: when differentiation goes awry[J]. Neuron, 2022, 110(18): 2916-2928.
[4] BOEVA V, LOUIS-BRENNETOT C, PELTIER A, et al. Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries[J]. Nat Genet, 2017, 49(9): 1408-1413.
[5] 蒋玉凤, 高怡瑾. 神经母细胞瘤的细胞分化和临床应用研究进展[J]. 国际儿科学杂志, 2023, 50(1): 23-28.
[6] JANESICK A, WU S C, BLUMBERG B. Retinoic acid signaling and neuronal differentiation[J]. Cell Mol Life Sci CMLS, 2015, 72(8): 1559.
[7] ZIMMERMAN M W, DURBIN A D, HE S, et al. Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastoma[J]. SciAdv, 7(43): eabe0834.
[8] 印螺, 吴旻. cDNA文库的建立、筛选及其应用(技术与方法)[J]. 国外医学. 遗传学分册, 1988(3): 113-116.
[9] 张瑾, 陈惠芬, 董瑞. 神经母细胞瘤细胞起源研究进展[J]. 中华小儿外科杂志, 2024, 45(5): 458-462.
[10] GARTLGRUBER M, SHARMA A K, QUINTERO A, et al. Super enhancers define regulatory subtypes and cell identity in neuroblastoma[J]. Nat Cancer, 2021, 2(1): 114-128.
[11] VAN GRONINGEN T, KOSTER J, VALENTIJN L J, et al. Neuroblastoma is composed of two super-enhancer-associated differentiation states[J]. Nat Genet, 2017, 49(8): 1261-1266.
[12] SAINT-ANDR?魪 V, FEDERATION A J, LIN C Y, et al. Models of human core transcriptional regulatory circuitries[J]. Genome Res, 2016, 26(3): 385-396.
[13] WEI L, CHEN J, SONG C, et al. Cancer CRC: a comprehensive cancer core transcriptional regulatory circuit resource and analysis platform[J]. Front Oncol, 2021, 11: 761700.
[14] MARTIK M L, BRONNER M E. Regulatory logic underlying diversification of the neural crest[J]. Trends genetics: TIG, 2017, 33(10): 715-727.
[15] MEACHAM C E, MORRISON S J. Tumour heterogeneity and cancer cell plasticity[J]. Nature, 2013, 501(7467): 328-337.
[16] KATTA S S, NAGATI V, PATURI ASV, et al. Neuroblastoma: emerging trends in pathogenesis, diagnosis, and therapeutic targets[J]. J Contr Rel, 2023, 357: 444-459.
[17] 杨成君, 王军. cDNA文库的构建策略及其应用[J]. 生物技术通报, 2007(1): 5-9.
[18] 张曦, 潘玉卿, 余鑫, 等. 人早幼粒细胞cDNA文库中与GINS2发生相互作用靶蛋白的筛选和鉴定[J]. 吉林大学学报(医学版), 2021, 47(1): 66-72.
[19] 张红英, 郭嘉雯, 员月明, 等. 人肺癌细胞A549λ噬菌体cDNA文库的构建与鉴定[J]. 西南医科大学学报, 2021, 44(4): 333-337.
[20] 赵静宇, 刘意抒, 方伟, 等. 新生隐球菌酵母双杂交cDNA文库的构建及鉴定[J]. 中国真菌学杂志, 2020, 15(3): 134-137.
[1]庞学明,侯爱林,王笑一,等.小儿神经母细胞瘤的MRI诊断[J].天津医科大学学报,2014,20(02):154.
[2]聂红艳,邱艳丽,靳 燕,等.TIAM1蛋白在神经母细胞瘤中的表达及临床意义[J].天津医科大学学报,2019,25(02):143.
NIE Hong-yan,QIU Yan-li,JIN Yan,et al.Expression and Clinical Significance of TIAM1 in Neuroblastoma[J].Journal of Tianjin Medical University,2019,25(05):143.
[3]杨倩玉,李璇,闫蓓蕾,等.通过生物信息学分析鉴定调控神经母细胞瘤骨髓转移的中枢基因[J].天津医科大学学报,2021,27(03):259.
YANG Qian-yu,LI Xuan,YAN Bei-lei,et al.Identification of hub genes to regulate neuroblastoma metastasis to bone marrow by bioinformatics analysis[J].Journal of Tianjin Medical University,2021,27(05):259.
[4]高伟靖,李龙.利用焦亡相关基因的特征预测神经母细胞瘤免疫微环境及其预后价值[J].天津医科大学学报,2023,29(04):379.
GAO Wei-jing,LI Long.Pyroptosis-related gene signature predicts the tumor microenvironment and prognosis in neuroblastoma[J].Journal of Tianjin Medical University,2023,29(05):379.